Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07120269) titled 'Predictive Markers of the Course of Covid-19 Based on Biomarker Serum Amyloid A (SAA) and Genetic Markers' on Aug. 1.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).
Primary Sponsor: Thomayer University Hospital
Condition:
COVID-19
Intervention:
Diagnostic Test: Nasal swab to collect material for RT-PCR SAA evaluation
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: February 10, 2021
Target Sample Size: 500
Countries of Recruitment:
Czechia
To know more, vis...